7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Osteoarthritis, Knee D020370 13 associated lipids
Lithiasis D020347 2 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Venous Thrombosis D020246 11 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Hot Flashes D019584 5 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Myositis, Inclusion Body D018979 3 associated lipids
Sepsis D018805 11 associated lipids
Arthralgia D018771 8 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Foot Injuries D018409 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Dzgoeva FU et al. [Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease]. 2014 Ter. Arkh. pmid:25095658
Wang F et al. Association analysis between g.18873C>T and g.27522G>A genetic polymorphisms of OPG and bone mineral density in Chinese postmenopausal women. 2014 Biomed Res Int pmid:25580430
Dessein PH et al. Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis. 2014 J. Rheumatol. pmid:24488413
Irtiuga OB et al. [Concentration of osteoprotegerin and RANKL in blood serum of patients with aortic stenosis]. 2014 Kardiologiia pmid:25178077
Zhang Z et al. High-dose diosgenin reduces bone loss in ovariectomized rats via attenuation of the RANKL/OPG ratio. 2014 Int J Mol Sci pmid:25257532
Kang JH et al. Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis. 2014 J. Dent. Res. pmid:25256714
Zinonos I et al. Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. 2014 Int. J. Oncol. pmid:24865346
Chaichanasakul T et al. Diverse osteoclastogenesis of bone marrow from mandible versus long bone. 2014 J. Periodontol. pmid:24003963
Marques EA et al. Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women. 2013 Sep-Oct Arch Gerontol Geriatr pmid:23623588
Liu S et al. Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women. 2013 Oct-Dec Hormones (Athens) pmid:24457406
Chiang PH et al. Zoledronic acid treatment for cancerous bone metastases: a phase IV study in Taiwan. 2013 Oct-Dec J Cancer Res Ther pmid:24518712
Canto-Cetina T et al. Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. 2013 Nov-Dec Am. J. Hum. Biol. pmid:24130145
Horshuns'ka MIu et al. [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. 2013 May-Jun Ukr Biokhim Zh (1999) pmid:23937044
Zamora PO et al. Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis. 2013 Mar-Apr Int. J. Toxicol. pmid:23422080
Esteghamati A et al. Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23877020
Glintborg D et al. Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23211475
Nanjundaiah SM et al. Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis. 2013 Jan-Mar Int J Immunopathol Pharmacol pmid:23527707
Guzel S et al. Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus. 2013 Diab Vasc Dis Res pmid:22496403
Wang ST et al. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria. 2013 Clin. Nephrol. pmid:23073066
Jin J et al. Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL/OPG ratio to impair osteoclast differentiation. 2013 J. Surg. Res. pmid:22487394
Ostrowska Z et al. Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa. 2013 Postepy Hig Med Dosw (Online) pmid:23752595
Uehara H et al. Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin. 2013 Int. J. Oncol. pmid:23708710
Luo J et al. 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. 2013 Biomed Res Int pmid:23710436
Neunaber C et al. Differentiation of osteoprogenitor cells is affected by trauma-haemorrhage. 2013 Injury pmid:23773407
Hakimi M et al. The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients. 2013 Int. J. Mol. Med. pmid:23722820
Marshall AJ et al. Long-chain triazolyl acids as inhibitors of osteoclastogenesis. 2013 Bioorg. Med. Chem. pmid:23726411
Brzóska MM and Rogalska J Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats. 2013 Toxicol. Appl. Pharmacol. pmid:23726800
Van Schepdael A et al. A mechanobiological model of orthodontic tooth movement. 2013 Biomech Model Mechanobiol pmid:22539046
Bauer S et al. Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study. 2013 Epilepsy Res. pmid:23916144
Nile CJ et al. Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease. 2013 J. Clin. Periodontol. pmid:23919740
Kim HR et al. The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients. 2013 Nephron Clin Pract pmid:23921088
Steensma MR et al. Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy. 2013 PLoS ONE pmid:23922683
Czyzewska-Buczyńska A et al. [Assessment of osteopontin and osteoprotegerin levels in abdominal aortic aneurysm patients]. 2013 Prz. Lek. pmid:24003660
Fathilah SN et al. Labisia pumila regulates bone-related genes expressions in postmenopausal osteoporosis model. 2013 BMC Complement Altern Med pmid:24007208
Einvik G et al. Novel cardiovascular risk markers in depression: no association between depressive symptoms and osteoprotegerin or adiponectin in persons at high risk for sleep apnea. 2013 J Affect Disord pmid:22862888
Koufany M et al. The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway. 2013 Arthritis Rheum. pmid:23982996
Mozzati M et al. Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid. 2013 Clin Oral Investig pmid:22864527
Wang J et al. Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system. 2013 Med. Hypotheses pmid:24074896
Kuo PL et al. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. 2013 Biochim. Biophys. Acta pmid:23458685
Li F et al. Effect of parathyroid hormone on experimental tooth movement in rats. 2013 Am J Orthod Dentofacial Orthop pmid:24075660
Sato K et al. RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer. 2013 Am. J. Pathol. pmid:23499553
Pneumaticos SG et al. Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications. 2013 Expert Opin. Ther. Targets pmid:24024908
Matuszewski Ł et al. Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using micro-computed tomography. 2013 Int Orthop pmid:23503639
Tarantino U et al. A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab. 2013 Aging Clin Exp Res pmid:24046047
Albers J et al. Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. 2013 J. Cell Biol. pmid:23401003
Nahidi L et al. Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation. 2013 Dig. Dis. Sci. pmid:24048682
Hope S et al. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. 2013 Schizophr. Res. pmid:23403415
Thormann U et al. Bone formation induced by strontium modified calcium phosphate cement in critical-size metaphyseal fracture defects in ovariectomized rats. 2013 Biomaterials pmid:23906515
D'Amico L et al. Bone metastases in gastric cancer follow a RANKL-independent mechanism. 2013 Oncol. Rep. pmid:23404437
Lekesiz K et al. Effect of unfractionated heparin, enoxaparin and sulodexide on the relations between secretion and expression of OPG, RANKL and vWF in HUVEC. 2013 Folia Histochem. Cytobiol. pmid:23907946
Briana DD et al. Relationships between maternal novel adipocytokines and bone biomarkers in complicated by gestational hypertensive disorders and normal pregnancies. 2013 J. Matern. Fetal. Neonatal. Med. pmid:23406471
Enhos S et al. OPG and RANKL levels around miniscrew implants during orthodontic tooth movement. 2013 Am J Orthod Dentofacial Orthop pmid:23910201
McDonald MM et al. Matrix metalloproteinase-driven endochondral fracture union proceeds independently of osteoclast activity. 2013 J. Bone Miner. Res. pmid:23408642
Oshita K et al. [Regulation of osteoclastogenesis by human mesenchymal stem cells leading to application of a novel treatment for rheumatoid arthritis]. 2013 J. UOEH pmid:23475022
Calderín S et al. Short-term clinical and osteoimmunological effects of scaling and root planing complemented by simple or repeated laser phototherapy in chronic periodontitis. 2013 Lasers Med Sci pmid:22546942
Kao SY et al. Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss. 2013 Neurobiol. Dis. pmid:23607938
Wu M et al. Vascular calcification: an update on mechanisms and challenges in treatment. 2013 Calcif. Tissue Int. pmid:23456027
Venojärvi M et al. 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation. 2013 Food Chem. Toxicol. pmid:23623841
Kitamura K et al. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts. 2013 Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. pmid:23632157
Shen L et al. Association between osteoprotegerin genetic variants and bone mineral density in Chinese women. 2013 Int. Immunopharmacol. pmid:23619553
Xie GQ et al. Relationship between serum TGF-β1, OPG levels and osteoporotic risk in native Chinese women. 2013 Clin. Chim. Acta pmid:23643930
Aranha AM et al. Evidence supporting a protective role for th9 and th22 cytokines in human and experimental periapical lesions. 2013 J Endod pmid:23228262
Ding CZ et al. [Effects of zhengqing fengtongning tablet and methotrexate on the serum OPG/RANKL and IL-17 of collagen-induced arthritis rats]. 2013 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:23646485
Jiang S et al. Changes of blood parameters associated with bone remodeling following experimentally induced fatty liver disorder in laying hens. 2013 Poult. Sci. pmid:23687138
Kim SJ et al. Compressive stress induced the up-regulation of M-CSF, RANKL, TNF-α expression and the down-regulation of OPG expression in PDL cells via the integrin-FAK pathway. 2013 Arch. Oral Biol. pmid:23219295
Kanzaki H et al. Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells. 2013 Exp. Mol. Pathol. pmid:23219833
Kim J et al. Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation. 2013 J. Bone Miner. Res. pmid:23633269
Wang H et al. Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening. 2013 Gene Ther. pmid:22318091
Hussien YM et al. Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. 2013 Mol. Biol. Rep. pmid:23271131
Tetè S et al. Maxillary sinus augmentation procedures through equine-derived biomaterial or calvaria autologous bone: immunohistochemical evaluation of OPG/RANKL in humans. 2013 Eur J Histochem pmid:23549459
Kuang B et al. Combined degenerative and regenerative remodeling responses of the mandibular condyle to experimentally induced disordered occlusion. 2013 Am J Orthod Dentofacial Orthop pmid:23273362
Matsuzaki E et al. Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. 2013 Bone pmid:23612487
Flórez-Moreno GA et al. Time-related changes in salivary levels of the osteotropic factors sRANKL and OPG through orthodontic tooth movement. 2013 Am J Orthod Dentofacial Orthop pmid:23273364
Brown TT et al. Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals. 2013 J. Acquir. Immune Defic. Syndr. pmid:23591634
Hyseni A et al. Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients. 2013 Thromb. Res. pmid:23273402
Engvall IL et al. Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP--a possible mechanism for specific inhibition of radiological destruction. 2013 Rheumatology (Oxford) pmid:23275387
Zhang Q et al. Local gene transfer of OPG prevents joint damage and disease progression in collagen-induced arthritis. 2013 ScientificWorldJournal pmid:24222748
Luo ZR et al. [A study of relationship between dialectical classification according to traditional Chinese medicine of acute coronary syndrome with serum osteoprotegerin and its ligand]. 2013 Zhonghua Wei Zhong Bing Ji Jiu Yi Xue pmid:24225213
Zhang F et al. Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women. 2013 Med. Oncol. pmid:23335067
Tisato V et al. GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients. 2013 Mediators Inflamm. pmid:24327798
Su SJ et al. Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line. 2013 Int J Food Sci Nutr pmid:23301724
Aoki A et al. Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes. 2013 Cardiovasc Diabetol pmid:23302066
Pathan E et al. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. 2013 Ann. Rheum. Dis. pmid:22984171
Ambroszkiewicz J et al. Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis. 2013 Adv Med Sci pmid:24277958
Wong KC et al. Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone. 2013 Br. J. Nutr. pmid:23302510
Wada T [RANKL inhibition in bone metastases]. 2013 Nippon Yakurigaku Zasshi pmid:23302944
Dorotheou D et al. Tooth eruption: altered gene expression in the dental follicle of patients with cleidocranial dysplasia. 2013 Orthod Craniofac Res pmid:23311656
Romagnoli C et al. Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. 2013 FEBS J. pmid:23176170
Revu S et al. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate. 2013 Arthritis Res. Ther. pmid:24295447
Kadkhodazadeh M et al. Analysis of RANKL gene polymorphism (rs9533156 and rs2277438) in Iranian patients with chronic periodontitis and periimplantitis. 2013 Arch. Oral Biol. pmid:23177932
Gutiérrez-Rojas I et al. Amylin exerts osteogenic actions with different efficacy depending on the diabetic status. 2013 Mol. Cell. Endocrinol. pmid:23178165
Barbieri G et al. Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement. 2013 Angle Orthod pmid:22716279
Bolzoni M et al. Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules. 2013 Exp. Hematol. pmid:23178378
Lee MH et al. The effect of surface microgrooves and anodic oxidation on the surface characteristics of titanium and the osteogenic activity of human periodontal ligament cells. 2013 Arch. Oral Biol. pmid:22717323
Dalcico R et al. Protective mechanisms of simvastatin in experimental periodontal disease. 2013 J. Periodontol. pmid:23181416
Balani D et al. Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro. 2013 Arthritis Rheum. pmid:23124514
Mercatali L et al. RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study. 2013 Int J Mol Sci pmid:23702841
Braun T et al. Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover. 2013 J. Bone Miner. Res. pmid:23169443
Rivadeneira F Hunting osteoporosis susceptibility genes: bigger is better but diverse is also welcome. 2013 Endocrine pmid:23001603
Scott JP et al. Effect of recovery duration between two bouts of running on bone metabolism. 2013 Med Sci Sports Exerc pmid:23034642

Table of Content